Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this single arm open label phase 1b clinical study is to see what effect
zoledronic acid has on tumors in patients with resectable any grade chondrosarcoma prior to
surgery.
Phase:
Phase 1
Details
Lead Sponsor:
Varun Monga Varun Monga, MD
Collaborators:
Rising Tide Foundation Rising Tide Foundation for Clinical Cancer Research